Your browser doesn't support javascript.
loading
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition.
Jennings, Victoria A; Scott, Gina B; Rose, Ailsa M S; Scott, Karen J; Migneco, Gemma; Keller, Brian; Reilly, Katrina; Donnelly, Oliver; Peach, Howard; Dewar, Donald; Harrington, Kevin J; Pandha, Hardev; Samson, Adel; Vile, Richard G; Melcher, Alan A; Errington-Mais, Fiona.
Afiliación
  • Jennings VA; The Institute of Cancer Research, Division of Radiotherapy and Imaging, Chester Beatty Laboratories, London SW3 6JB, UK; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Scott GB; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Rose AMS; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Scott KJ; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Migneco G; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Keller B; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Reilly K; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Donnelly O; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Peach H; St James's University Hospital, Leeds LS9 7TF, UK.
  • Dewar D; St James's University Hospital, Leeds LS9 7TF, UK.
  • Harrington KJ; The Institute of Cancer Research, Division of Radiotherapy and Imaging, Chester Beatty Laboratories, London SW3 6JB, UK.
  • Pandha H; Leggett Building, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7WG, UK.
  • Samson A; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
  • Vile RG; Mayo Clinic, Rochester, MN 55905, USA.
  • Melcher AA; The Institute of Cancer Research, Division of Radiotherapy and Imaging, Chester Beatty Laboratories, London SW3 6JB, UK. Electronic address: alan.melcher@icr.ac.uk.
  • Errington-Mais F; Section of Infection and Immunity, Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
Mol Ther ; 27(6): 1139-1152, 2019 06 05.
Article en En | MEDLINE | ID: mdl-31053413
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Ácido Valproico / Simplexvirus / Virus Oncolíticos / Viroterapia Oncolítica / Inhibidores de Histona Desacetilasas / Melanoma Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Ácido Valproico / Simplexvirus / Virus Oncolíticos / Viroterapia Oncolítica / Inhibidores de Histona Desacetilasas / Melanoma Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos